Back to results
US 2022/0064172 A1Published application
Pyrrolopyrimidine derivative and use thereof
AssigneeWuhan Humanwell Innovative Drug Research and Development Center Limited Company
InventorsXuejun ZHANG, Dabing YE, Lie LI, Jie SHEN, Xiaohua DING, Hongna SUN, Zhe LIU, Yang ZANG, Yonggang WEI
Life of this patent
Estimating the term…
Abstract
Provided is a new compound capable of effectively inhibiting ATX. The compound is represented by formula I, or the compound is a tautomer, a stereoisomer, a hydrate, a solvate, a salt, or a prodrug of the compound represented by formula I. In formula (I), R1 and R2 are independently selected from —H or —CH3, provided that: R1 and R2 are not —H at the same time or are not —CH3 at the same time.
Claims15
A compound, being a compound represented by Formula I;
- or being a tautomer, a stereoisomer, a hydrate, a solvate, a salt, or a prodrug of the compound represented by Formula I,
- wherein,
- R1 and R2 are each independently selected from —H or —CH3,
- provided that:
- when R1 and R2 are not —H simultaneously;
- or
- when R1 and R2 are not —CH3 simultaneously.
4 more elements
Dependencies are inferred from the claim text.